Publication result detail
Liposomal Form of Erlotinib for the Inhalation Drug Delivery
SZABOVÁ, J.; MIŠÍK, O.; FUČÍK, J.; MRÁZOVÁ, K.; MRAVCOVÁ, L.; KRZYZANEK, V.; LÍZAL, F.; MRAVEC, F.
Original Title
Liposomal Form of Erlotinib for the Inhalation Drug Delivery
English Title
Liposomal Form of Erlotinib for the Inhalation Drug Delivery
Type
Abstract
Original Abstract
This contribution is focused on the encapsulation of erlotinib to liposomes with different properties which are suitable for inhalation drug delivery.
English abstract
This contribution is focused on the encapsulation of erlotinib to liposomes with different properties which are suitable for inhalation drug delivery.
Keywords
Liposome, Inhalation, Erlotinib, Nebulization, Non-small cell lung cancer
Key words in English
Liposome, Inhalation, Erlotinib, Nebulization, Non-small cell lung cancer
Authors
SZABOVÁ, J.; MIŠÍK, O.; FUČÍK, J.; MRÁZOVÁ, K.; MRAVCOVÁ, L.; KRZYZANEK, V.; LÍZAL, F.; MRAVEC, F.
Released
20.10.2022
Publisher
Tanger Ltd.
Location
Ostrava, CZ
Book
Nanocon 2022 – Abstracts
Pages from
89
Pages to
89
Pages count
1
BibTex
@misc{BUT179651,
author="Jana {Szabová} and Ondrej {Mišík} and Jan {Fučík} and Kateřina {Mrázová} and Ludmila {Mravcová} and Vladislav {Krzyžánek} and František {Lízal} and Filip {Mravec}",
title="Liposomal Form of Erlotinib for the Inhalation Drug Delivery",
booktitle="Nanocon 2022 – Abstracts",
year="2022",
edition="1",
pages="89--89",
publisher="Tanger Ltd.",
address="Ostrava, CZ",
note="Abstract"
}